Top News

Otonomy Up In IPO

San Diego-based biopharmaceuticals firm Otonomy was up today in early trading, after pricing 6.25 million shares of its common stock at $16.00 per share last night. The company was trading around $17.52 today after its debut on the NASDAQ Global Market as OTIC. The company raised $100M in the IPO. The company priced at the high end of its initial estimated IPO range, which was $14.00 to $16.00 per share. The company is developing treatments for disorders of the inner ear. Otonomy was backed by Avalon Ventures, OrbiMed, Novo A/S, TPG Biotechnology Partners, Domain Associates, and Rivervest Venture Partners.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel